APOE and Alzheimer disease: Given that APOE serves as a principal lipid carrier in cholesterol metabolism and is significantly correlated with the risk of AD, a comprehensive understanding of the competitive interactions between APOE-GM1 and APOE-cholesterol lipoproteins could facilitate the development of targeted therapeutic strategies aimed at modulating lipid homeostasis and enhancing cellular functionality in AD and other neurodegenerative conditions.